Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
The U.S. demands Gavi eliminate thimerosal from vaccines for future funding, despite scientific consensus on its safety.
The U.S. government has told Gavi it must phase out thimerosal, a mercury-based vaccine preservative, to receive future funding, citing safety concerns despite scientific consensus that it is safe.
The condition applies to both pending and future U.S. contributions, following a prior $300 million funding cut.
Gavi, which supports immunization in low-income countries, says any changes require scientific approval and board consent.
Thimerosal remains in use in multi-dose vials due to cost and distribution advantages, especially in developing nations.
The move reflects broader U.S. efforts to shape global health policy under the 'America First' agenda, amid cuts to international health programs and the withdrawal from the WHO.
Estados Unidos exige que Gavi elimine el timerosal de las vacunas para financiamiento futuro, a pesar del consenso científico sobre su seguridad.